Leaders in Pharmaceutical Business Intelligence (LPBI) Group

SUBSIDIARY #5

DrugDiscovery @LPBI Group

Team Profile

Team Profile: DrugDiscovery @LPBI Group – A BioTech Start Up submitted for Funding Competition to MassChallenge Boston 2016 Accelerator

http://pharmaceuticalintelligence.com/2016/03/29/team-profile-drugdiscovery-lpbi-group-a-biotech-start-up-submitted-for-funding-competition-to-masschallenge-boston-2016-accelerator/

From: MassChallenge <contact@masschallenge.org>

Reply-To: <contact@masschallenge.org>

Date: Saturday, April 2, 2016 at 3:17 PM

To: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>

Subject: MC Update – Applications Close 

Click to Browse the 2016 Startup Applicants

We are DrugDiscovery@LPBI Group – Boston 2016 – Health/Life Sciences

– Three Indications:

• Diabetes – A Combination Drug Therapy to induce Insulin Production by Pancreatic Beta Cells (PPAR-gamma, Leptin, ..)
• Inflammatory Disorders: Inflammatory Bowel Diseases (IBD) – Crohn’s and Ulcerative Colitis (UC) and Others
• Anti-Cancer Drug Discovery @ LPBI Group’s Research Biotech Businesses

 

 

JOINT VENTURES for Intellectual Property Development 

JVIP

SBH Sciences, Inc. & LPBI Group’s M3DP, Subsidiary #3

 

Drug Discovery with 3D BioPrinting

– Diabetes (PPAR-gamma, Leptin, ..) IP: List of Clinical Trials (SJW) – done

– Inflammatory Disorders: IBD – IP: List of anti-Inflammatory in Clinical Trials (Stuart) – done

– Anti-Cancer CAR-T – IP: Immune-Oncology: List of Clinical Trials (SJW) – work-in-progress

Drug Delivery System – One solution for many agents for many indications

– Prof. Kost, BGU – License Options 

(BioEngineering, 2008 article, See Bob Langer as co-author in References)

Stem Cell Transformation 

– Adipose Cells to Pancreatic Beta Cells

– Skin Cells to Pancreatic Beta Cells

Gene Editing for Gene Therapies with 3D BioPrinting

– BioMEMS

– Oglionucleotides Chips

– Transposomes

OTHER PRODUCT CONCEPTS

• Dr. Codrington’s Diagnostics Kit for Skin Cancer targeted at US Clinical Medical Labs
• Dr. Pearlman’s Product Concept of a Cell BioFactory: Applications other than 5.2
• Dr. Pearlman’s Product Concept of an Artificial Kidney

This page has the following sub pages.

• SBH Sciences, Inc. & LPBI Group’s M3DP, Subsidiary #3
• Drug Discovery with 3D BioPrinting
• Drug Delivery System – One solution for many agents for many indications
• Stem Cell Reprogramming & Gene Therapy
• Gene Editing for Gene Therapies with 3D BioPrinting
• JVIP – TEAM PRESENTATIONS 1/4/2016 – 3/31/2016